1. Home
  2. VVX vs IMNM Comparison

VVX vs IMNM Comparison

Compare VVX & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo V2X Inc.

VVX

V2X Inc.

HOLD

Current Price

$65.72

Market Cap

2.0B

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$20.01

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVX
IMNM
Founded
2014
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
VVX
IMNM
Price
$65.72
$20.01
Analyst Decision
Buy
Strong Buy
Analyst Count
10
9
Target Price
$62.60
$31.44
AVG Volume (30 Days)
397.9K
3.4M
Earning Date
02-23-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
791.53
N/A
EPS
2.51
N/A
Revenue
$4,419,142,000.00
$9,679,000.00
Revenue This Year
$4.53
N/A
Revenue Next Year
$5.14
$11.53
P/E Ratio
$25.94
N/A
Revenue Growth
5.10
N/A
52 Week Low
$41.08
$5.15
52 Week High
$65.50
$25.30

Technical Indicators

Market Signals
Indicator
VVX
IMNM
Relative Strength Index (RSI) 74.68 48.09
Support Level $54.09 $19.60
Resistance Level $56.38 $22.01
Average True Range (ATR) 1.87 1.12
MACD 1.05 -0.26
Stochastic Oscillator 91.12 22.51

Price Performance

Historical Comparison
VVX
IMNM

About VVX V2X Inc.

V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: